175,000-Woman NHS Study Finds AI Catches More Breast Cancers and Cuts Radiologists’ Reading Time by a Third
A 175,000-woman NHS study found AI acting as a second mammogram reader caught more invasive cancers, produced fewer false positives, and cut radiologists' scan-reading time by nearly a third, adding fuel to the health service's push toward wider AI screening trials.
Smart Rings Are Quietly Outgrowing Smartwatches, and Ultrahuman Just Proved It Can Be Profitable
Ultrahuman posted $64 million in revenue and its first-ever profit in fiscal 2025, a 5.4x jump that helped it land a $70 million round led by Qualcomm Ventures — part of a smart ring category now growing faster than smartwatches.
Oura Builds Its First In-House AI Model, and It’s Entirely About Women’s Bodies
Oura launched its first proprietary AI model on February 24, 2026, built specifically to give personalized cycle, fertility, pregnancy and menopause guidance using a member's own biometric data — all processed on Oura's own servers rather than sent to outside AI providers.
Nvidia Wants to Train Hospital Robots in a Simulated Hospital Before They Ever Touch a Patient
Nvidia unveiled a healthcare robotics platform, including a hospital digital-twin blueprint called Rheo, designed to train clinical robots in simulation before they ever touch a real patient.
A Single Phishing Email at an AI Vendor Exposed 1.4 Million Patient Records From Eight Health Systems
A phishing attack on AI utilization-management vendor Xsolis exposed the medical and personal data of 1.4 million patients across eight U.S. health systems, including Mayo Clinic and UW Medicine.
AI-Designed Lung Drug Rentosertib Enters Phase III, a First for Idiopathic Pulmonary Fibrosis
Insilico Medicine has begun a Phase III trial of rentosertib, an AI-designed drug for idiopathic pulmonary fibrosis, marking the first AI-discovered therapy for the disease to reach late-stage testing.
Five States Now Bar AI Chatbots From Practicing Therapy, and More Are Writing the Rules
Illinois, Nevada, Rhode Island and Maine now ban AI chatbots from practicing therapy outright, while Utah, California and Colorado are instead forcing chatbots to disclose they're not human — a patchwork that's reshaping how AI mental-health apps operate state by state.
After a Decade of Delays, Johnson & Johnson’s Ottava Surgical Robot Finally Wins FDA Approval
Johnson & Johnson's Ottava surgical robot finally won FDA authorization in July 2026 after more than a decade of delays, entering a soft-tissue robotic surgery market suddenly crowded with new AI-guided rivals.
Eli Lilly Fires Up World’s Most Powerful Pharma Supercomputer to Hunt for New Drugs
Eli Lilly has switched on LillyPod, a 1,016-GPU NVIDIA supercomputer delivering over 9,000 petaflops — a bet that owning frontier-scale AI compute is now essential to compete in drug discovery.